Efficacy results for treatment group compared to control group
Efficacy outcomes were also compared between the treatment and control groups at week 24. The treatment group showed significantly greater improvement on each outcome at week 24 compared with the control group, with moderate-to-large effect sizes ranging from 0.53 for the MOS-I to 1.29 for the CGI-I responder rate (For the control group, the remaining improvements at week 24 relative to baseline (